Targeting epigenetic regulators to overcome drug resistance in cancers
N Wang, T Ma, B Yu - Signal transduction and targeted therapy, 2023 - nature.com
Drug resistance is mainly responsible for cancer recurrence and poor prognosis. Epigenetic
regulation is a heritable change in gene expressions independent of nucleotide sequence …
regulation is a heritable change in gene expressions independent of nucleotide sequence …
Targeting epigenetic regulation for cancer therapy using small molecule inhibitors
A Kumar, L Emdad, PB Fisher, SK Das - Advances in Cancer Research, 2023 - Elsevier
Cancer cells display pervasive changes in DNA methylation, disrupted patterns of histone
posttranslational modification, chromatin composition or organization and regulatory …
posttranslational modification, chromatin composition or organization and regulatory …
GSK-J4, a Specific Histone Lysine Demethylase 6A Inhibitor, Ameliorates Lipotoxicity to Cardiomyocytes via Preserving H3K27 Methylation and Reducing Ferroptosis
K Xu, X Liu, B Wen, Y Liu, W Zhang, X Hu… - Frontiers in …, 2022 - frontiersin.org
Changes in modern lifestyle provoke a series of metabolic stresses such as hyperlipidemia.
Excessive free fatty acids induce cardiomyocyte metabolic reprogramming and …
Excessive free fatty acids induce cardiomyocyte metabolic reprogramming and …
The role of lysine-specific demethylase 6A (KDM6A) in tumorigenesis and its therapeutic potentials in cancer therapy
LJ Chen, XY Xu, XD Zhong, YJ Liu, MH Zhu, F Tao… - Bioorganic …, 2023 - Elsevier
Histone demethylation is a key post-translational modification of chromatin, and its
dysregulation affects a wide array of nuclear activities including the maintenance of genome …
dysregulation affects a wide array of nuclear activities including the maintenance of genome …
Drugging hijacked kinase pathways in pediatric oncology: Opportunities and current scenario
MF Candido, M Medeiros, LC Veronez, D Bastos… - Pharmaceutics, 2023 - mdpi.com
Childhood cancer is considered rare, corresponding to~ 3% of all malignant neoplasms in
the human population. The World Health Organization (WHO) reports a universal …
the human population. The World Health Organization (WHO) reports a universal …
Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma
Summary Prostaglandin E 2 (PGE 2) promotes tumor cell proliferation, migration, and
invasion, fostering an inflammation-enriched microenvironment that facilitates angiogenesis …
invasion, fostering an inflammation-enriched microenvironment that facilitates angiogenesis …
SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7
ZM Zhang, HB Cao, ZH Li, R Zhuo, YF Tao, XL Li… - Cell death & …, 2022 - nature.com
Recent studies uncovered the emerging roles of SAPCD2 (suppressor anaphase-promoting
complex domain containing 2) in several types of human cancer. However, the functions and …
complex domain containing 2) in several types of human cancer. However, the functions and …
Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells
X Song, Y Lan, X Zheng, Q Zhu, X Liao, K Liu… - MedComm, 2023 - Wiley Online Library
Drug resistance remains the greatest challenge in improving outcomes for cancer patients
who receive chemotherapy and targeted therapy. Surmounting evidence suggests that a …
who receive chemotherapy and targeted therapy. Surmounting evidence suggests that a …
Hypoxic condition induced H3K27me3 modification of the LncRNA Tmem235 promoter thus supporting apoptosis of BMSCs
F Zhang, H Luo, W Peng, L Wang, T Wang, Z Xie… - Apoptosis, 2022 - Springer
Bone marrow mesenchymal stem cells (BMSCs) have strong regenerative potential and
show good application prospects for treating clinical diseases. However, in the process of …
show good application prospects for treating clinical diseases. However, in the process of …
[HTML][HTML] Immune microenvironment heterogeneity reveals distinct subtypes in neuroblastoma: insights into prognosis and therapeutic targets
Y Yang, H Li, D Zheng, X Li, H Liu - Aging (Albany NY), 2023 - ncbi.nlm.nih.gov
Background: Neuroblastoma (NB) is a childhood cancer originating from immature nerve
cells in the sympathetic nervous system. Current clinical and molecular subtyping methods …
cells in the sympathetic nervous system. Current clinical and molecular subtyping methods …